A pharmaceutical composition comprising: a) a 5-HT1 agonist b) an NSAID and c) a disintegrant characterised in that the disintegrant comprises between about 15 to about 50% w/w based on the weight of the composition, said composition optionally comprising one or more other pharmaceutically acceptable excipients.
